JP2024533313A5 - - Google Patents
Info
- Publication number
- JP2024533313A5 JP2024533313A5 JP2024515069A JP2024515069A JP2024533313A5 JP 2024533313 A5 JP2024533313 A5 JP 2024533313A5 JP 2024515069 A JP2024515069 A JP 2024515069A JP 2024515069 A JP2024515069 A JP 2024515069A JP 2024533313 A5 JP2024533313 A5 JP 2024533313A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- grna
- mutation
- gene
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163241994P | 2021-09-08 | 2021-09-08 | |
| US63/241,994 | 2021-09-08 | ||
| US202163250143P | 2021-09-29 | 2021-09-29 | |
| US63/250,143 | 2021-09-29 | ||
| US202263303900P | 2022-01-27 | 2022-01-27 | |
| US63/303,900 | 2022-01-27 | ||
| PCT/US2022/076063 WO2023039440A2 (en) | 2021-09-08 | 2022-09-07 | Hbb-modulating compositions and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024533313A JP2024533313A (ja) | 2024-09-12 |
| JP2024533313A5 true JP2024533313A5 (cg-RX-API-DMAC7.html) | 2025-09-17 |
Family
ID=85506910
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024515069A Pending JP2024533313A (ja) | 2021-09-08 | 2022-09-07 | Hbbを調節する組成物及び方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240252682A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4399307A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024533313A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022342169A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3231679A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW202323524A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023039440A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150166984A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting alpha-antitrypsin point mutations |
| AU2019327449B2 (en) | 2018-08-28 | 2026-04-09 | Flagship Pioneering Innovations Vi, Llc | Methods and compositions for modulating a genome |
| BR112022017715A2 (pt) | 2020-03-04 | 2022-11-16 | Flagship Pioneering Innovations Vi Llc | Métodos e composições para modular um genoma |
| IL296095A (en) | 2020-03-04 | 2022-11-01 | Flagship Pioneering Innovations Vi Llc | Improved methods and compositions for genome modulation |
| CA3177481A1 (en) | 2020-05-08 | 2021-11-11 | David R. Liu | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
| CA3231712A1 (en) | 2021-09-08 | 2023-03-16 | Flagship Pioneering Innovations Vi, Llc | Pah-modulating compositions and methods |
| IL312965A (en) * | 2021-11-24 | 2024-07-01 | Flagship Pioneering Innovations Vi Llc | Immunogenic compositions and their uses |
| CN118251485A (zh) | 2022-08-12 | 2024-06-25 | 宝洁公司 | 固体可溶性组合物 |
| US12655369B2 (en) | 2022-08-12 | 2026-06-16 | The Procter & Gamble Company | Solid dissolvable compositions comprising capsules |
| WO2024036117A1 (en) | 2022-08-12 | 2024-02-15 | The Procter & Gamble Company | Low-water compositions |
| EP4684023A2 (en) * | 2023-03-21 | 2026-01-28 | Tessera Therapeutics, Inc. | Modified template guide rna molecules |
| WO2024206125A1 (en) * | 2023-03-24 | 2024-10-03 | The Broad Institute, Inc. | Use of prime editing for treating sickle cell disease |
| AU2024342487A1 (en) * | 2023-09-13 | 2026-04-30 | Tessera Therapeutics, Inc. | Lipid nanoparticles for delivery of therapeutic payloads to cells |
| WO2025128871A2 (en) | 2023-12-13 | 2025-06-19 | Renagade Therapeutics Management Inc. | Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents |
| WO2025174765A1 (en) | 2024-02-12 | 2025-08-21 | Renagade Therapeutics Management Inc. | Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents |
| WO2026060316A1 (en) * | 2024-09-13 | 2026-03-19 | Tessera Therapeutics, Inc. | Lipid nanoparticles for delivery of therapeutic payloads to cells |
| WO2026064481A1 (en) * | 2024-09-20 | 2026-03-26 | Harpe Bioherbicide Solutions, Inc. | Glucosyltransferase genes conferring herbicide tolerance |
| WO2026099887A1 (en) * | 2024-11-05 | 2026-05-15 | Crisprbits Private Limited | "guide rna and method of detection of sickle cell disease" |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6974349B2 (ja) * | 2016-04-18 | 2021-12-01 | クリスパー セラピューティクス アクチェンゲゼルシャフト | ヘモグロビン異常症の処置のための材料及び方法 |
| SG10202109385QA (en) * | 2016-07-05 | 2021-10-28 | Univ Johns Hopkins | Crispr/cas9-based compositions and methods for treating retinal degenerations |
| WO2020191241A1 (en) * | 2019-03-19 | 2020-09-24 | The Broad Institute, Inc. | Methods and compositions for editing nucleotide sequences |
| AU2020344547A1 (en) * | 2019-09-09 | 2022-03-24 | Beam Therapeutics Inc. | Novel nucleobase editors and methods of using same |
| US12435330B2 (en) * | 2019-10-10 | 2025-10-07 | The Broad Institute, Inc. | Methods and compositions for prime editing RNA |
-
2022
- 2022-09-07 EP EP22868285.2A patent/EP4399307A4/en active Pending
- 2022-09-07 CA CA3231679A patent/CA3231679A1/en active Pending
- 2022-09-07 JP JP2024515069A patent/JP2024533313A/ja active Pending
- 2022-09-07 AU AU2022342169A patent/AU2022342169A1/en active Pending
- 2022-09-07 WO PCT/US2022/076063 patent/WO2023039440A2/en not_active Ceased
- 2022-09-08 TW TW111134206A patent/TW202323524A/zh unknown
-
2024
- 2024-02-28 US US18/590,275 patent/US20240252682A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024533312A5 (cg-RX-API-DMAC7.html) | ||
| JP2024533315A5 (cg-RX-API-DMAC7.html) | ||
| US5714353A (en) | Safe vectors for gene therapy | |
| JP6799058B2 (ja) | アレル選択的な遺伝子編集およびその使用 | |
| EP3356520B1 (en) | Lentiviral protein delivery system for rna-guided genome editing | |
| JP2023529315A (ja) | 機能的aavカプシドのハイスループット工学操作 | |
| US12129478B1 (en) | Engineered adenosine deaminases and base editors thereof | |
| JP2024533313A (ja) | Hbbを調節する組成物及び方法 | |
| BR112020008733A2 (pt) | método de resgate de códons de parada através de reatribuição genética com ace-trna | |
| WO2016149484A2 (en) | Compositions and methods for specific reactivation of hiv latent reservoir | |
| WO2024131940A1 (zh) | 融合物及其用途 | |
| JP2020530463A (ja) | ウイルスの細胞内送達のためのペプチドおよびナノ粒子 | |
| JP2024525602A (ja) | 切断不活性Cas12F1、切断不活性Cas12F1ベースの融合タンパク質、これを含むCRISPR遺伝子調節システム、その製造方法及び用途 | |
| JP7736329B2 (ja) | Dux4遺伝子を標的とした顔面肩甲上腕型筋ジストロフィーの治療方法 | |
| WO2024238321A1 (en) | Compositions and methods for targeted epigenetic modification | |
| CN118147120A (zh) | 胞苷脱氨酶及碱基编辑器 | |
| KR102876548B1 (ko) | Francisella novicida Cas9 모듈 기반의 역전사 효소를 사용한 유전체 치환 및 삽입 기술 | |
| AU2022343271A1 (en) | Recruitment in trans of gene editing system components | |
| WO2021230385A1 (en) | Method for treating muscular dystrophy by targeting utrophin gene | |
| WO2022003608A1 (en) | Mirna-485 inhibitor for huntington's disease | |
| IL323066A (en) | PAH Modulating Systems and Methods | |
| JP2026509461A (ja) | Serpina調節性組成物及び方法 | |
| JPH11502706A (ja) | シュードタイプレトロウイルス粒子 | |
| JP2024522216A (ja) | インフラマソーム関連疾患または障害を治療するためのmirna-485阻害剤の使用 | |
| RU2801848C1 (ru) | Генетическая конструкция, адаптированная для доставки гена SMN1 человека с помощью аденоассоциированного вируса серотипа 2 для обеспечения нейроспецифичной экспрессии |